Century Therapeutics (IPSC) Current Assets (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Current Assets data on file, last reported at $139.0 million in Q1 2026.

• Current Assets for Q1 2026 came in at $139.0 million, down 18.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $139.0 million (down 18.03% YoY), and the FY2025 annual result was $120.8 million, down 37.76% from the prior year.
• Current Assets advanced to $139.0 million in Q1 2026 per IPSC's latest filing, from $120.8 million in the prior quarter.
• Over five years, Current Assets peaked at $383.8 million in Q2 2022 and troughed at $120.8 million in Q4 2025.
• A 5-year average of $219.4 million and a median of $194.1 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2023: Current Assets soared 40.13% in 2022, then plunged 57.98% in 2023.
• A 5-year view of Current Assets shows it stood at $319.7 million in 2022, then sank by 44.64% to $177.0 million in 2023, then gained by 9.64% to $194.1 million in 2024, then plunged by 37.76% to $120.8 million in 2025, then grew by 15.13% to $139.0 million in 2026.
• Business Quant data shows IPSC's Current Assets at $139.0 million in Q1 2026, $120.8 million in Q4 2025, and $137.7 million in Q3 2025.